All filters
Abstracts
Changes in hepatic fibrosis stages after achieving SVR following direct acting antiviral treatment in children with chronic hepatitis C
R. Soliman Reviews in Antiviral Therapy & Infectious Diseases 11, 2020
Presented at:
International Viral Hepatitis Elimination Meeting (IVHEM) 2020
Abstracts
External validation of GES score to predict HCC risk in patients with HCV associated significant hepatic fibrosis following DAAs in genotype 1 and 2 in Japan.
G. Shiha Reviews in Antiviral Therapy & Infectious Diseases 11, 2020  
Presented at:
International Viral Hepatitis Elimination Meeting (IVHEM) 2020
Abstracts
Decentralized testing and treatment of hepatitis C in people who inject drugs– the Shared Addiction Care Copenhagen (SACC) project
C. Sølund Reviews in Antiviral Therapy & Infectious Diseases 11, 2020
Presented at:
International Viral Hepatitis Elimination Meeting (IVHEM) 2020
Abstracts
A novel hepatitis C intervention in Denmark to test and treat people who inject drugs
J. Lazarus Reviews in Antiviral Therapy & Infectious Diseases 11, 2020
Presented at:
International Viral Hepatitis Elimination Meeting (IVHEM) 2020
Abstracts
Collocating Hepatitis C Care at Syringe Exchange Programs: Hepatitis C treatment with Less Stigma.
Y. Aponte-Melendez Reviews in Antiviral Therapy & Infectious Diseases 11, 2020  
Presented at:
International Viral Hepatitis Elimination Meeting (IVHEM) 2020
Abstracts
Re-linkage to care: a novel strategy to achieve hepatitis C elimination in a University Hospital
M. Mendizabal  Reviews in Antiviral Therapy & Infectious Diseases 11, 2020
Presented at:
International Viral Hepatitis Elimination Meeting (IVHEM) 2020
Abstracts
Recall of HCV patients lost to follow-up. ReLinK study in two expert centres in France
V. de Ledinghen  Reviews in Antiviral Therapy & Infectious Diseases 11, 2020
Presented at:
International Viral Hepatitis Elimination Meeting (IVHEM) 2020
Abstracts
A successful hepatitis C outreach service in a medically supervised injecting room: increased uptake of screening and high rates of treatment initiation
M. Macisaac Reviews in Antiviral Therapy & Infectious Diseases 11, 2020  
Presented at:
International Viral Hepatitis Elimination Meeting (IVHEM) 2020
Abstracts
Dual Sofosbuvir/Daclatasvir Therapy for Chronic Hepatitis C Infection: Lessons from Our Studies in Pediatric Age Groups
M. Yakoot Reviews in Antiviral Therapy & Infectious Diseases 11, 2020  
Presented at:
International Viral Hepatitis Elimination Meeting (IVHEM) 2020
Abstracts
Progress towards achieving hepatitis C elimination in the country of Georgia, April 2015 – June 2020
T. Tsertsvadze  Reviews in Antiviral Therapy & Infectious Diseases 11, 2020
Presented at:
International Viral Hepatitis Elimination Meeting (IVHEM) 2020
Abstracts
A Novel Approach Continuum from Identification to Elimination in HCV-Infected Individuals on Opioid Substitution Therapy and High-Risk Populations
T. Stainbrook Reviews in Antiviral Therapy & Infectious Diseases 11, 2020
Presented at:
International Viral Hepatitis Elimination Meeting (IVHEM) 2020
Abstracts
Risks factors associated with HIV and hepatitis C virus co-infection among people who inject drugs in Cambodia
C. Saing Reviews in Antiviral Therapy & Infectious Diseases 11, 2020
Presented at:
International Viral Hepatitis Elimination Meeting (IVHEM) 2020
Abstracts
A Model for Collaborative Care to Increase Testing and Treatment of HCV in a Shelter Population During COVID-19
N. Gale Reviews in Antiviral Therapy & Infectious Diseases 11, 2020
Presented at:
International Viral Hepatitis Elimination Meeting (IVHEM) 2020
Abstracts
Concordance between FibroScan® and Aspartate aminotransferase-to-Platelet Ratio Index (APRI) using different cut-off values in 301 Asian adults with chronic HCV with no or compensated cirrhosis in Thailand and Malaysia
T. Soek-Siam Reviews in Antiviral Therapy & Infectious Diseases 11, 2020
Presented at:
International Viral Hepatitis Elimination Meeting (IVHEM) 2020
Abstracts
Strategies for population-based screening and treatment of hepatitis B in sub-Saharan Africa: a mathematical modelling study in The Gambia
N. Schmit  Reviews in Antiviral Therapy & Infectious Diseases 11, 2020
Presented at:
International Viral Hepatitis Elimination Meeting (IVHEM) 2020
Abstracts
Sustained reduction in prevalence of Hepatitis C viremina in the prison setting after 3rd year of TraPHepC (Treatment as prevention for hepatitis C) program in Iceland
R. Fridriksdottir Reviews in Antiviral Therapy & Infectious Diseases 11, 2020
Presented at:
International Viral Hepatitis Elimination Meeting (IVHEM) 2020
Abstracts
The Effect of COVID-19 on the Hepatitis C Screening in Georgia
A. Aslanikashvili Reviews in Antiviral Therapy & Infectious Diseases 11, 2020
Presented at:
International Viral Hepatitis Elimination Meeting (IVHEM) 2020
Abstracts
Reducing Read Time of Point of Care Test Preserves Detection of Hepatitis C Virus and Reduces Need for Reflex RNA
D. Smookler  Reviews in Antiviral Therapy & Infectious Diseases 11, 2020
Presented at:
International Viral Hepatitis Elimination Meeting (IVHEM) 2020
Abstracts
Frequency of Occult Hepatitis B Virus among blood Donors in Khartoum State, Sudan: a preliminary study.
M. Yassin Reviews in Antiviral Therapy & Infectious Diseases 11, 2020
Presented at:
International Viral Hepatitis Elimination Meeting (IVHEM) 2020
Abstracts
A novel point -of- care test (POC) for diagnosis of hepatitis Core antigen
G. Shiha  Reviews in Antiviral Therapy & Infectious Diseases 11, 2020
Presented at:
International Viral Hepatitis Elimination Meeting (IVHEM) 2020
Abstracts
Validation of a novel point-of-care ALT test to determine treatment eligibility in hepatitis B patients: a pilot cohort study
J. Howell Reviews in Antiviral Therapy & Infectious Diseases 11, 2020
Presented at:
International Viral Hepatitis Elimination Meeting (IVHEM) 2020
Abstracts
Hepatitis C Epidemic and Barriers to Testing among MSM with High Risk Behaviors in China: A GSN-delivered Cross-sectional Study
Y. Tang Reviews in Antiviral Therapy & Infectious Diseases 11, 2020
Presented at:
International Viral Hepatitis Elimination Meeting (IVHEM) 2020
Abstracts
Drug resistance of hepatitis C virus to NS5A protein inhibitors in Belarus
E. Gasich Reviews in Antiviral Therapy & Infectious Diseases 11, 2020  
Presented at:
International Viral Hepatitis Elimination Meeting (IVHEM) 2020
Abstracts
Seroprevalence of Hepatitis B and C Among HIV-infected Children and Adolescents Receiving Antiretroviral Therapy in Anambra State, Nigeria
S. Kalu  Reviews in Antiviral Therapy & Infectious Diseases 11, 2020  
Presented at:
International Viral Hepatitis Elimination Meeting (IVHEM) 2020